rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Lupin Ltd.

500257 LUPIN Group (A)

01 Oct,15:29
2190.10
-0.10 (-0.00%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Lupin Ltd.

BUYSELL

11,016 2,190.20 2,207.65 - 2,175.25 2,312.00 - 1,113.00 99,890.47
NSE | BSE

Lupin Ltd.

LUPIN

01 Oct,15:54
2194.40
3.30 (0.15%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Lupin Ltd.

BUYSELL

786,650 2191.1 2,219.00 - 2,175.05 2,312.00 - 1,123.00 17,252.73

News for Lupin Ltd.

Lupin Partners...
Lupin Partners with Scope Ophthalmics for Mexican Eyecare Market
Lupin has partnered with Scope Ophthalmics to market a range of eyecare products in Mexico, including products for dry eyes, blepharitis, and MGD.
Sep 30, 2024 17:54
Lupin Gets USFDA...
Lupin Gets USFDA Observations for Pithampur Plant
Lupin receives six observations from the USFDA following an inspection of its Pithampur plant in Madhya Pradesh. The company is addressing the observations and will respond within the stipulated...
Sep 28, 2024 16:06
Lupin Partners...
Lupin Partners with Celnova for Drug Distribution in South America
Lupin's subsidiary has partnered with Celnova Pharma to distribute NaMuscla, a drug for non-dystrophic myotonic disorders, in Argentina and Colombia. The partnership aims to provide innovative...
Sep 27, 2024 18:45
Lupin Signs...
Lupin Signs Patent License for Gastrointestinal Drug in India
Lupin has entered into a patent license agreement with Takeda to commercialise Vonoprazan tablets, a novel gastrointestinal drug, in the Indian market. The drug will be marketed under the brand...
Sep 18, 2024 14:01
Sunsure Energy...
Sunsure Energy Secures Rs 10,000 Cr Loan for Green Energy
Sunsure Energy signs a Rs 10,000 crore loan agreement with REC for green energy projects, aimed at developing 3 GW of solar, wind, and hybrid energy. This partnership will accelerate India's...
Sep 18, 2024 13:53

More News for Lupin Ltd. »

(Rs. Crore)

Financial Results of Lupin Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales14,666.5011,258.8311,771.6711,055.9311,025.66
Operating profit3,459.061,082.66275.712,044.061,907.61
Interest56.3598.4473.4740.6252.59
Gross profit3,509.441,075.48352.662,132.532,330.21
EPS (Rs)51.049.35-4.1527.7416.06

See more in Research Center »

About Lupin Ltd.

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Wikipedia

News for Pharmaceuticals and health care

BP to Continue...
BP to Continue Oil & Gas Ventures with Reliance in India
BP's exclusivity with Reliance Industries has ended but the energy giant will continue to pursue oil and gas ventures with the Mukesh Ambani firm in India.
Oct 02, 2024 12:58
Bombay Stock...
Bombay Stock Exchange Brokers' Forum Appoints New Chairman
The Bombay Stock Exchange Brokers' Forum (BBF) has appointed Anup Gupta as its new chairman, succeeding Kishor Kansagra. Gupta brings extensive financial expertise to the role.
Oct 02, 2024 12:44
Royal Enfield...
Royal Enfield Sales Surge 11% in September
Royal Enfield's wholesales rose 11% to 86,978 units in September, driven by strong domestic demand and new model launches.
Oct 02, 2024 12:34
Jubilant Agro...
Jubilant Agro Sciences Inks Pact for Agro Intermediate Production
Jubilant Agro Sciences has partnered with a leading agrochemical company to produce an agro intermediate, expected to generate over USD 300 million in revenue over the next few years.
Oct 02, 2024 12:16
Real Estate...
Real Estate Investment Soars 45% in Q3 2024: Colliers
Institutional investments in Indian real estate surged to USD 1.15 billion in July-September, driven by strong demand for premium homes and offices. Colliers reports office segment attracting USD...
Oct 02, 2024 11:02

More News »

Top News

BP to Continue...
BP to Continue Oil & Gas Ventures with Reliance in India
BP's exclusivity with Reliance Industries has ended but the energy giant will continue to pursue oil and gas ventures with the Mukesh Ambani firm in India.
Oct 02, 2024 12:58
Bombay Stock...
Bombay Stock Exchange Brokers' Forum Appoints New Chairman
The Bombay Stock Exchange Brokers' Forum (BBF) has appointed Anup Gupta as its new chairman, succeeding Kishor Kansagra. Gupta brings extensive financial expertise to the role.
Oct 02, 2024 12:44
Royal Enfield...
Royal Enfield Sales Surge 11% in September
Royal Enfield's wholesales rose 11% to 86,978 units in September, driven by strong domestic demand and new model launches.
Oct 02, 2024 12:34
Jubilant Agro...
Jubilant Agro Sciences Inks Pact for Agro Intermediate Production
Jubilant Agro Sciences has partnered with a leading agrochemical company to produce an agro intermediate, expected to generate over USD 300 million in revenue over the next few years.
Oct 02, 2024 12:16
Singapore's Role in Bengaluru's Tech Hub Development
Singapore has been a key partner in Bengaluru's tech growth over the past 30 years, fostering innovation and attracting global talent. Learn about their collaboration at the Bengaluru Tech Summit...
Oct 02, 2024 11:51

More Top News »

Report Card

PE Ratios
42.91
EPS (Rs.)
51.04
Sales (Rs. Cr)
4,167.63
Face Value (Rs.)
2
Net Profit Margin (%)
15.85
Last Bonus
1:1
Last Dividend(%)
400
Return on Average Equity
11.35

Compare 'Lupin Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,926.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,757.90
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,068.35
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,195.75
  • Compare
  • Max Healthcare Institute Ltd.
  • 985.45
  • Compare
  • Alkem Laboratories Ltd.
  • 6,060.90
  • Compare
  • Divi's Laboratories Ltd.
  • 5,446.20
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,399.75
  • Compare

Most Active

  • Change (Rs.)
  •  

Lupin Ltd. performance snapshot

If you had invested Rs.  in Lupin Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Lupin Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Lupin Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close